Oruka TherapeuticsORKA
那斯達克 · USD
30.21
-1.19
(-3.79%)
收盤 12/12 04:59 (UTC+8)
盤後
30.81
+0.60
(+1.99%)
12/12 04:59 (UTC+8)
Oruka TherapeuticsORKA
30.21
-1.19
(-3.79%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- 0.00
- 0.00
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 0 | 0 | 0 | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | 0 | 0 | - | - | - | - | - | - |
營業費用 | 34,105 | 28,429 | 25,086 | - | 29,449 | 3,122 | 2,482 | 1,590 | 1,937 |
研發費用 | 28,988 | 24,087 | 19,925 | - | 25,691 | 130 | 165 | 47 | 322 |
推銷及管理費用 | 5,117 | 4,342 | 5,161 | - | 3,758 | 2,992 | 2,317 | 1,543 | 1,615 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - |
營業利益 | -34,105 | -28,429 | -25,086 | - | -29,449 | -3,122 | -2,482 | -1,590 | -1,937 |
其他收入及費用 | - | - | - | - | 1,330 | 444 | 473 | 501 | 513 |
利息費用 | 0 | 0 | 0 | - | 504 | - | - | - | - |
稅前純益 | -30,277 | -24,574 | -20,999 | - | -28,623 | -2,678 | -2,009 | -1,089 | -1,424 |
所得稅 | - | - | - | - | - | - | - | - | - |
稅後純益 | -30,277 | -24,574 | -20,999 | - | -28,623 | -2,678 | -2,009 | -1,089 | -1,424 |
基本每股稅後盈餘(元) | -0.55 | -0.46 | -0.40 | - | -1.46 | -0.76 | -0.24 | - | - |
稀釋每股稅後盈餘(元) | -0.55 | -0.46 | -0.40 | - | -1.46 | 16.32 | -20.16 | -0.96 | -1.08 |
基本平均股數(千股) | 44204.00 | 42233.00 | 41679.00 | - | 15063.00 | 29398.00 | 29398.00 | - | - |
稀釋平均股數(千股) | 44204.00 | 42233.00 | 41679.00 | - | 15063.00 | 29398.00 | 29398.00 | - | - |
還原基本每股稅後盈餘(元) | -0.55 | -0.46 | -0.40 | - | -1.46 | -0.76 | -0.24 | - | - |
還原稀釋每股稅後盈餘(元) | -0.55 | -0.46 | -0.40 | - | -1.46 | 16.32 | -20.16 | -0.96 | -1.08 |
還原基本平均股數(千股) | 44,204 | 42,233 | 41,679 | - | 15,063 | 29,398 | 29,398 | - | - |
還原稀釋平均股數(千股) | 44,204 | 42,233 | 41,679 | - | 15,063 | 29,398 | 29,398 | - | - |
EBITDA(千元) | -30,257 | -24,555 | -20,983 | 0 | -28,119 | -2,666 | -1,990 | -1,066 | -1,394 |